Modulation of matrix remodeling by SPARC in neoplastic progression

Author(s): Chlenski A, Cohn SL

Abstract

SPARC is a matricellular glycoprotein that mediates interactions between cells and their microenvironment. It is produced at sites of tissue remodeling, where it regulates matrix deposition and turnover, cell adhesion, and signaling by extracellular factors, exerting profound effects on tissue architecture and cell physiology. During extensive matrix remodeling in neoplastic progression, SPARC is expressed in cancer-associated stroma and in malignant cells of some types, affecting tumor development, invasion, metastases, angiogenesis and inflammation. SPARC-induced changes in the tumor microenvironment can suppress or promote progression of different cancers depending on the tissue and cell type. Understanding the mechanism of matrix remodeling and its regulation by SPARC is essential for the development of new treatment strategies for highly aggressive cancers.

Similar Articles

Osteonectin, a bone-specific protein linking mineral to collagen

Author(s): Termine JD, Kleinman HK, Whitson SW, Conn KM, McGarvey ML, et al.

Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma

Author(s): Mantoni TS, Schendel RR, Rödel F, Niedobitek G, Al-Assar O, et al.

Frequent inactivation of SPARC by promoter hypermethylation in colon cancers

Author(s): Yang E, Kang HJ, Koh KH, Rhee H, Kim NK, et al.

Fibroblasts in cancer

Author(s): Kalluri R, Zeisberg M

CD34+ fibrocytes in neoplastic and inflammatory pancreatic lesions

Author(s): Barth PJ, Ebrahimsade S, Hellinger A, Moll R, Ramaswamy A